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Abstract Complementary DNA clones encoding a novel 
protein, ABC-C, with the typical structural features of the 
ABC transporter family were identified in a human medullary 
thyroid carcinoma cell line. The transporter consists of 1704 
amino acid residues with two homologous repeats, each 
harboring six putative transmembrane helices and an ATP- 
binding cassette motif. The mRNA is expressed highest in normal 
lung, but also in varying amounts in other tissues and in C-cell 
carcinoma. The ABC-C gene is mapped on chromosome 16p13.3, 
in close physical proximity to another ABC transporter, the 
multidrug resistance-associated protein. This related protein is 
assumed to confer resistance to chemotherapeutic drugs in small 
cell lung carcinoma. The genomic lustering of both transporters, 
typical also for other members of the ABC family, supports the 
notion that ABC-C may be involved in development of resistance 
to xenobiotics. 
Key words: ABC transporter; Chemotherapy; 
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1. Introduction 
The resistance of malignant tumors to chemotherapy is con- 
sidered to be partly due to overexpression f transmembrane 
transport proteins. The human multidrug resistance protein 
(MDR) and probably the multidrug resistance-associated pro-
tein (MRP) utilize the energy of ATP hydrolysis to pump 
chemotherapeutic drugs out of the cells. Both proteins are 
members of the ATP-binding cassette (ABC) superfamily, 
which are encoded by one of the largest and diverse gene 
families (reviewed in [1,2]). Many ABC transporters are of 
considerable clinical significance not only for conferring resist- 
ance to chemotherapeutics, butalso as drug targets. The re- 
ceptor for sulfonylurea is a member of the ABC transporter 
family which binds the orally active antidiabetics and regu- 
lates the opening of a potassium channel [3]. This receptor is 
mutated in patients with persistent hyperinsulinemic hypogly- 
cemia of infancy [4]. Mutation of genes encoding ABC trans- 
porters are involved in diverse hereditary diseases uch as 
cystic fibrosis, adrenoleukodystrophy andin defects in antigen 
processing [5-7]. 
Gene transfer experiments with MDR1 cDNA have demon- 
strated that the expression of P-glycoprotein is sufficient o 
transfer the multidrug resistance phenotype to drug-sensitive 
cells [8]. P-glycoprotein functions as an ATP-dependent e ttux 
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pump that reduces the intracellular ccumulation of cytotoxic 
agents. It interacts directly with a variety of antineoplastic 
drugs and transports them out of the cells. 
The widespread occurrence of drug resistance cannot solely 
be explained by the overexpression f the P-glycoprotein. In
thyroid cancer, a very low frequency of MDR1 expression was 
found by the RT-PCR technique [9]. The expression of the 
MDRl-related MRP transporter was highest in anaplastic 
carcinoma, in which tumor MRP was present in over 50% 
of the tissues [10]. However, other carcinomas such as papil- 
lary, follicular or medullary carcinoma had a very low or no 
expression of the MRP transporter. In addition, a human 
medullary thyroid carcinoma TT cell line did not express 
the P-glycoprotein, although the effects of chemotherapeutic 
drugs were potentiated by verapamil and cyclosporin A [11]. 
In order to elucidate the existence of additional ABC trans- 
porters which may contribute to drug resistance in thyroid 
cancer we used a human medullary thyroid carcinoma cell 
line for a cDNA cloning approach. A new member of the 
ABC transporter family could be identified. It shows the typ- 
ical structural features of these transmembrane proteins, such 
as the putative four domain topology and the conserved mo- 
tifs of the ATP-binding cassettes. Since the cDNA clone ori- 
ginated from human medullary thyroid C-cells it is designated 
as ABC-C. 
2. Materials and methods 
2.1, Isolation of RNA and Northern blot analysis 
Total RNA from a human C-cell carcinoma was isolated by the 
guanidinium thiocyanate method and poly(A) RNA was separated by 
oligo(dT) cellulose chromatography (Poly(A) Quik mRNA Isolation 
Kit, Stratagene). Poly(A) RNA from hMTC cells was purified using 
the Fast Track Kit (Invitrogen). Poly(A) RNA from hMTC cells and 
from the C-cell carcinoma was fractionated on a 1.2% agarose gel, 
transferred to nylon membranes (Pall) and hybridized under high 
stringency. The human multiple tissue Northern Blot was obtained 
from Clontech. The random primed labeled 1308 bp SacI fragment 
was used as probe; this region shares no significant homology with 
other sequences of ABC transporters. 
2.2. cDNA library construction 
Poly(A) RNA from hMTC cells was reverse transcribed and dou- 
ble-strand cDNA was synthesized using the Superscript lasmid sys- 
tem (Gibco BRL Life Technologies). The cDNA fragments were li- 
gated with BstXI/EcoRI adaptors (Invitrogen). The cDNA was size- 
fractionated on a low melting agarose gel (FMC SeaPlaque GTG 
agarose, BIOzym) and only gel slices containing fragments > 4000 
bp were excised and digested with GELase (BIOzym). The cDNA 
was ligated into the BstXI site of the pcDNAII vector (Invitrogen) 
and transformed into the E. coli XL1-Blue MRF' strain (Stratagene). 
A degenerate oligonucleotide rived from the conserved sequence 
motif of ABC transporters was used to screen the library under low 
stringency two times. Several clones hybridized with different autora- 
diographic signal strength to the oligonucleotide probe. Only clones 
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1 MAVLRQLALLLWKN•TLQKRKVLVTVLELFL•LLFSGIL IWLRLKIQSENVPNATIYPGQSIQELPLFFTFPPPGDTWELAYIPSHSDAA 90 
91 KTVTETVRRAL•INMRVRGFPSEKDFEDYIRYDN•SSSVLAAVVFEHPFNHSKE•LPLA•KYHLRFSYTRRNYMWTQTGSFFLKETEGWH 180 
181 TTSLF•LF•N•G•RE•TS•DGGEPGY•REGFLA•QHAVDRAIMEYHADAATRQLFQRLTVTIKRF•Y••FIADPFLVAIQYQLPLLLLLS 270 
S1 
271 FTYTALT IARAwQEKERRLKEYMRMMGLSSWLHWSAWFLLFFLFLL IAASFMTLLFCVKVKpNVAVLSRSD•SLVLAFLLCFAIST ISF  300 
$2 s3 
361 SFMvSTFFSKANMAAAFGGFLYFFTYIPYFFvAPRYNWMTLSQKLCSCLLSNvAMAMGAQLIGKFEAKGMGIQWRDLLS•vNvDDDFCFG 450 
$4 $5 
451 QvLGMLLLDSVLYGLvTWYMEAvFPGQFGvPQPWYFFIMPSYWCGKPRAVAGKEEEDSDPEKALRNEYFEAEPEDLVAGIKIKHLSKvFR 540 
$6 
541 vGNI~R.~a~.VRDLNLNLYEGQITVLI-~RN~GKTrTLSMLTGLFPpTSG~YISGYEISQDNVQIRKSLGLCPQI-~ILFDNL'~W~HLYFY I 630 
ATP b ind ing  casset te  
63~AQLKGL~RQKCPEEVKQMLHI IGLEDKWN~SRFLSGGMRRKLS IG IAL IAGSKVL~LDE~TS~4DAISRRAIWDLLQRQ~SDRTIVLTT  720 
721 HFMDEADLLGDRIA IMAKGELQCCGSSLFLKQKYGAGYHMTL~KE~H~N~EDISQL~NATLESSAGAELSF IL~RESTHRFEGLF  810 
811 AKLEKKQKELGIASFGASITTMEEVFLRVGKLVDSSMDIQAIQLPALQYQHERRASDWAVDSNLCGAMDpSDGIGALIEEERTAVKLNTG 900 
901 LALHCQQFWAMFLKKAAYSWREWKMvAAQvLV•LTcvTLALLAINYSSELFDD•MLRLTLGEYGRTVv•FS••GTSQLGQQLSEHLKDAL 990 
991 QAEGQE•REvLGDLEEFL IFRAS•EGGGFNERCL•AASFRD•GERTVvNALFNNQAYHS•ATALAvVDNLLFKLLCG•HASIwSNF•Q• 1080 
1081 RSALQAAKDQFNEGRKGFDIALNLLFAMAFLASTFS ILAvSERAvQAKHVQFvSGvHvASFWLSALLWDLISFL IPSLLLLwFKAFDvR 1170 
S1 $2 
1171 AFTRDGHMADTLLLLLLYGWAI IpLMYLMNFFFLGAATAYTRLTIFNILSGIATFLMVTIMRIPAvKLEELSKTLDHvFLvLpN}{CLGMA 1260 
$3 $4 $5 




ATP binding cassette 
1531 ~E~A~IFLDE~TG~P~ARRLLWDTVARARESGKAIIITSHSMEECEALCTRLAIMVQGQFKCLGS~QHLKSKFGSGYSLRAKVQSEGQ 1620 
1621 QEALEEFKAFvDLTFPGSVLEDEHQGMVHYHL•GRDLSWAKvFGILEKAKEKYGvDDY•VSQISLEQvFLSFAHLQP•TAEEGR 1704 
Fig. 1. Primary structure of ABC-C. The amino acid sequence was deduced from its cDNA. The suggested locations of the transmembrane seg- 
ments are designated by horizontal ines. The conserved motifs of the ATP-binding cassettes are indicated by the open bars. Potential phos- 
phorylation sites by cAMP kinase are underlined and marked with asterisks. 
which were positive in both rounds of screening were analyzed further 
by restriction digestion and by sequencing. Two of the 20 analyzed 
clones had an almost identical restriction analysis pattern. 
2.3. Sequence analysis 
Sequencing was performed using the Thermo Sequenase cycle se- 
quencing protocol (Amersham) in combination with the A.L.F. DNA 
sequencer (Pharmacia Biotech). pABC18 was digested with different 
restriction endonucleases and the resulting cDNA fragments were 
subcloned into pUC18. Fluorescent labelled M13 universal and re- 
verse primers were used for sequencing both strands. Sequence 
stretches with no available subclone were analyzed by specific primers 
and by the dideoxy chain termination method on double-stranded 
templates (USB Sequenase 2.0). The sequence is available under ac- 
cession umber X97187 at the EMBL nucleotide sequence database. 
3. Results and discussion 
3.1. Primary structure 
Screening of a hMTC cDNA library revealed two positive 
independent clones, pABC18 and pABC52. The complete nu- 
cleotide sequence of pABC18 consists of 6246 bp, pABC52 is 
5 bp longer at the 3'-untranslated region, but 54 bp shorter at 
the 5'-untranslated region. The identity of both clones was 
proved by a detailed restriction analysis and by sequencing 
of several subclones. The deduced open reading frame of 
pABC18 comprises 5112 bp encoding a 1704 amino acid pro- 
tein with a calculated molecular mass of 191 360 Da (Fig. 1). 
The putative translational start codon is the first in-frame 
ATG codon of the open reading frame. Several termination 
codons upstream of the initiation site of translation indicate 
that both clones represent full-length cDNAs. The region di- 
rectly upstream of the translational start site resembles the 
consensus equence for eukaryotic initiation sites with an A 
base at position -3  and a G base at +4 relative to the start 
codon. The Y-untranslated region contains one consensus 
polyadenylation signal very close to the Y-end of the cDNA 
fragment, but both clones have no poly(A) tail. 
Hydropathy analysis predicts a structure reminiscent of that 
of the largest ABC transporters, uch as multidrug resistance 
N. Klugbauer, F. HofmannlFEBS Letters 391 (1996) 61~5 63 
I I I I I I I I ~ I I I I I I 
0 500 i000  1500 
Fig, 2. Hydropathy analysis according to Kyte and Doolittle [18]. The curve is the average of a residue specific hydrophobicity index over a 
window of nine residues. The line in the upper half indicates hydrophobic regions and that in the lower half hydrophilic regions. Putative trans- 
membrane segments are black colored. Lower part: Schematic representation f the location of the putative transmembrane regions and of the 
ATP-binding cassettes. 
P-glycoprotein or CFTR (Fig. 2). ABC-C shows the typical 
domain composition consisting of two repeats each with six 
transmembrane segments and an ATP binding cassette motif. 
Assuming an intracellular N-terminus, as is the case for all 
other mammalian ABC transporters, the ABC-C transporter 
consists of three cytoplasmic regions and two transmembrane 
regions. Only some short sequence stretches connecting the 
transmembrane s gments are located extracellularly. How- 
ever, the intracellular loop between both repeats contains 
two additional hydrophobic regions and it is possible that 
they are also embedded in the membrane. An extra hydro- 
phobic segment has also been identified in the ABC1 and 
ABC2 transporters which have been identified in a murine 
macrophage c ll line [12]. The murine ABC1 and ABC2 trans- 
porter show the closest relationship to ABC-C. Comparative 
sequence analysis between ABC-C and the mouse ABC1 
transporter reveals 40% identical and 62% similar amino 
acids. However, this low degree of similarity indicates that 
ABC-C does not represent the corresponding human protein 
of one of the murine transporters. 
The multidrug resistance protein MDR1 [13] and its asso- 
ciated protein MRP [14] are 50% and 44% homologous to 
ABC-C, respectively. MDR1 and MRP are only distantly re- 
lated to each other. Sequence comparisons with other mem- 
ABC-C (N) AVRDLNLNLYEGQITVL  TLSMLTGLFPPTSGRAYISGYEISQDMVQ- IRKSLGLCPQHDILFDNLTVAEHLYFYAQLKGLSRQKC 641 
mABC1 (N) AVDGLALNFYEGQITSF  TMSILTGLFPPTSGTAYILGKDIRSEMSS- IRQNLGVCPQHNVLFDMLTVEEHIWFYARLKGLSEKHV 948 
hMDRI (N) ILKGLNLKVQSGQTV TVQLMQRLYDPTEGMVSVDGQDIRT INVRFLREI IGWSQEPVLFATT IAENIRYGRENVTMDEIEKA 503 
hMRP (N) TLNGITFS IPEGALVA LLSALLAEMDKVEGHVAIKGS . . . . . . . . . . . . .  VAYVPQQAWIQNDSLRENILFGCQLEEPYYRSVI  741 
WA 
ABC-C (N) - - -PEEVKQMLHI IGL-EDKWNSRSR RRKLS IG IAL IAGSK TSGMDAISRRAIWDLLQRQKSDRTIVLTTHFMDEADLLGDR 732 
mABC1 (N) - - -KAEMEQMALDVGLPPSKLKSKTS QRKLSVALAFVGGS TAGVDPYSRRGIWELLLKYRQGRTI ILSTHHMDEADILGDR 1040 
hMDRI (N) VY.EANAYDFIMKLPHKFDTLVGERG KQRIAI~d~ALXrR/qp TS~ILDTESEAVVQVALDKARKGRTTIV I~qRLSTVRNADVI  591 
hMRP (N) QACALLPDLE IL -PSGDRTEIGEKGV~-~KQR~SLARAvYSNAD~LSAVDAHvGKHIFENVIGPKGMLKNKTRILvTHSMSYLPQV 835 
ATS WB 
ABC-C (C) AVDRLSLAVQKGECFGL TFKMLTGEESLTSGDAFVGGHRISSDVGK-VRQRIGYCPQFDALLDHMTGREMLVMYARLRGIPERHI  1491 
m~BC1 (C) AVDRIC IG IPPGECFGL KMLTGDTPVTRGDAFLNKNSILSNIHE-XrHQNMGYCPQFDAITELLTGREHVEFFALLRGVPEF-~V 1961 
hMDR1 (C) VLQGLSLEVKKGQTL/~L QLLERFYDPLAGKVLLDGK~IKR~QWLI~LGIVSQEP ILFDCSIAENIAYGDNSRWSQEEIV  1146 
b_MRP (C) VLRHINVT INGGEKvGI~LTLGLFRINEsAEGEI I IDGIN IAK IGLHDLRFKIT I IPQDPVLFSGSLRMNL- - -DPFSQYSDEEvW 1403 
WA 
ABC-C (C) .. . . . .  GACVENTLRGLLLEPHANKL KLSTGIAL IGEP  STGMDPVARRLLWDTVARARESGKAI I ITSHSMEECEAL 1580 
~LABCI (C) .. . . . .  GKFGEWAIRKLGLArKYGEKYAS KLSTAYJiLIGGP~ TTGMDPKARRFLWNCALSIVKEGRSV%FLTSHSMEECEAL 2050 
hMDRI (C) ~ IHAF IESLPNKYSTKVGDKG RIAIA~3~LVRQP TSALDTESEKVVQEgtLDK/d~EGRTCIVI~=qRLSTIQNAD 1241 
bAMRP (C) TSLE Ia~/qL~-DFvS l~LPD~-LDHE~AEGG~RQLVCLAp-ALLRKT~TAAvDLETDDLIQST IRTQFEDCT~rLT I /~RL~qTIMDYT 1495 
ATS WB 
Fig. 3. Multialignment of the extended nucleotide-binding cassettes from ABC-C, ABC1, MDR1 and MRP. The amino-terminal (N) and car- 
boxy-terminal (C) located sequences are aligned at the positions indicated. The conserved Walker A and B motifs (WA and WB) and the active 
transport family signature (ATS) characteristic of nucleotide-binding folds of ABC transporters are indicated. 




Fig. 4. Northern blot analysis of poly(A) RNA from hMTC cells, a 
C-cell carcinoma nd different human tissues. Left part: 5 ~tg of 
poly(A) RNA isolated from hMTC cells and from a C-cell carcino- 
ma was hybridized with an ABC-C specific probe. The film was ex- 
posed for 2 days. Right part: Autoradiograph of 2 I.tg of poly(A) 
RNA from normal human tissues. Time of exposure was 16 h. 
bers of the ABC transporter family revealed similarity values 
below 45%. 
The highest degree of homology resides in the two con- 
served motifs of the ATP-binding cassettes (Fig. 3). The se- 
quence identity extends over the entire domains and is larger 
than within the two short stretches of the Walker motifs 
[1,15]. The Walker A motif corresponds to a glycine-rich 
loop known to be involved in phosphoryl transfer in many 
nucleotide-binding proteins. The active transport signature 
(ATS, Fig. 3) is located a certain distance upstream of the 
Walker B motif. 
3.2. Database search and chromosomal mapping 
The European Molecular Biology Laboratory and the 
TIGR human cDNA database were searched for similar se- 
quences to ABC-C using different programs (Blastn, Blastp, 
Tblastn). Several expressed sequence tags from human brain 
and fetal lung libraries hared identical sequence stretches, but 
none of the partial clones extended more than several hundred 
base pairs. Therefore they are far from representing the full- 
length cDNA. At the genomic DNA level the database search 
revealed that part of ABC-C is 100% identical to clone exon 
trap b76, which was identified by exon trapping of the region 
involved in polycystic kidney disease (accession number 
L48760, Burn, T.C., Connors, T.D., Landes, G.M. and Klin- 
ger, K.W., unpublished). This exon has been mapped to chro- 
mosome 16p13.3. The identity over the entire exon sequence 
clearly demonstrates that the ABC-C transporter is encoded in 
the same chromosomal region. Recently, it was shown that 
the gene coding for the MRP is located at the same chromo- 
some band p13.3 [14]. As already suggested by these authors 
additional genes on the same chromosomal band may be re- 
sponsible for or contribute to the multidrug resistance pheno- 
type of a lung cancer cell line. The close physical proximity of 
the gene locus indicates that ABC-C could be this candidate. 
Linkage of gene loci for members of the ABC transporter 
family can also be observed for the human CFTR and 
MDR1 proteins, which have been mapped to chromosome 7 
at bands q31 and q21, respectively [16,17]. In situ hybridiza- 
tion using the murine ABC1 and ABC2 cDNAs as probes on 
human chromosome spreads identified the ABC1 and ABC2 
genes on chromosome 9 region q22-q31 and q34, respectively 
[12]. This result and the low degree of sequence similarity 
support further the notion that ABC-C is not the human 
homolog of one of the murine proteins. 
3.3. Expression of ABC-C 
Northern blot analysis of mRNA from hMTC cells and 
from a solid C-cell carcinoma both show a single transcript 
of 7.5 kb (Fig. 4). The same transcript is present in different 
human tissues, although with variations in abundance. ABC- 
C is expressed highest in lung but is also clearly detectable in
brain and pancreas, expression is lower in heart and skeletal 
muscle. An overnight exposure is sufficient o observe mRNA 
in these tissues. Prolonged autoradiography demonstrates that 
ABC-C transcripts of the same size can be identified also in 
placenta, kidney and liver at low amounts (not shown). 
According to the expression of MRP, which is readily de- 
tectable in lung, ABC-C is most abundant in lung. Both the 
amounts of MRP and ABC-C mRNA in the normal ung are 
considerably higher than those detected in the cell lines from 
which they were initially isolated (for discussion see [12]). 
Some cell types in the lung or in the thyroid gland may be 
inherently drug-resistant because of an increased constitutive 
expression of MRP or ABC-C, respectively. In contrast, the 
expression pattern of MRP in other tissues is quite different 
from that of ABC-C. MRP transcripts for example are not 
observed in brain, placenta, kidney and liver. 
The genomic lustering of ABC-C with MRP together with 
the conserved omain structure indicates that ABC-C may be 
functionally related and may act as an efflux pump for chemo- 
therapeutic drugs. However, the distinct expression pattern of 
MDR, MRP and ABC-C suggests that their physiological 
roles may differ. 
Acknowledgements. We thank Mrs. Erhard, Mrs. Stief and Mrs. 
Mayr for expert technical assistance. The work was supported by 
the Deutsche Forschungsgemeinschaft andFonds der Chemie. 
References 
[1] Higgins, C.F. (1992) Annu. Rev. Cell Biol. 8, 67-113. 
[2] Higgins, C.F. (1995) Cell 82, 693-696. 
[3] Inagaki, N., Gonoi, T. Clement, J.P. IV, Namba, N., Inazawa, J., 
Gonzalez, G., Aguilar-Bryan, L., Seino, S. and Bryan, J. (1995) 
Science 270, 1166-1170. 
[4] Thomas, P.M., Cote, G.J., Wohlik, N., Haddad, B., Mathew, 
P.M., Rabl, W., Aguilar-Bryan, L., Gagel, R.F. and Bryan, J. 
(1995) Science 268, 426-429. 
[5] Riordan, J.R., Rommens, J.M., Kerem, B.-S., Alon, N., Rozma- 
hel, R. Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, 
N. Klugbauer, F. Hofmann/FEBS Letters 391 (1996) 6145 65 
J.L., Drumm, M.L., Iannuzzi, M.C., Collins, F.S. and Tsui, L.C. 
(1989) Science 245, 1066-1073. 
[6] Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., 
Moser, H., Poustka, A.-M. Mandel, J.-L. and Aubourg, P. (1993) 
Nature 361,726-730. 
[7] Kelly, A., Powis, S.H., Kerr, L.-A., Mockridge, I., Elliott, T., 
Bastin, J., Uchanska-Ziegler, B., Ziegler, A., Trowsdale, J. and 
Townsend, A. (1992) Nature 355, 641-644. 
[8] Gottesman, M.M. and Pastan, I. (1993) Annu. Rev. Biochem. 62, 
385-427. 
[9] Sugawara, I., Arai, T., Yamashita, T., Yoshida, A., Masunaga, 
A. and Itoyama, S. (1994) Cancer Lett. 82, 185-188. 
[10] Sugawara, I., Masunaga, A., Itoyama, S., Sumizawa, T., 
Akiyama, S. and Yamashita, T. (1995) Cancer Lett. 95, 135-138. 
[11] Larsson, R. and Nygren, P (1990) Cancer Lett. 54, 125-131. 
[12] Luciani, M.F., Denizot, F., Savary, S., Mattai, M.G. and Chi- 
mini, G. (1994) Genomics 21, 150-159. 
[13] Chen, C.-J., Chin, J.E., Ueda, K., Clark, D.P., Pastan, I., Gottes- 
man, M.M. and Roninson, I.B. (1986) Cell 47, 381-389. 
[14] Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, 
C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, 
A.M.V. and Deeley, R.G. (1992) Science 258, 1650-1654. 
[15] Walker, J.E., Saraste, M., Runswick, J. and Gay N.J. (1982) 
EMBO J. 1, 945. 
[16] Callen, D.F., Baker, E., Simmers, R.N., Seshadri, R. and Ronin- 
son, I.B. (1987) Hum. Genet. 77, 142. 
[17] Duncan, A.M.V., Buchwald, M. and Tsui, L.-C. (1988) Cytogen- 
et. Cell Genet. 49, 309. 
[18] Kyte and Doolittle (1982) J. Mol. Biol. 157, 105-132. 
